| PubMed |
Abstract |
RScore(About this table) |
| 16229137 |
Basova NE, Rozengart EV: Inhibition of cholinesterases of various origin by anabasine derivatives. Dokl Biochem Biophys. 2005 Jul-Aug;403:261-5.
|
81(1,1,1,1) |
Details |
| 12741131 |
Rozengart EV: Bisalkaloid derivatives of dicarboxylic acids on the basis of lupinine, anabasine, and cytisine as reversible cholinesterase inhibitors. Dokl Biochem Biophys. 2003 Jan-Feb;388:39-42.
|
31(0,1,1,1) |
Details |
| 15481367 |
Rozengart EV, Basova NE: [Application of bisalkaloid derivatives of dicarboxylic acids based on lupinine, anabasine and cytisine as cholinesterase inhibitors of various origin] Zh Evol Biokhim Fiziol. 2004 Jul-Aug;40(4):305-10.
|
31(0,1,1,1) |
Details |
| 9243321 |
Summers KL, Kem WR, Giacobini E: Nicotinic agonist modulation of neurotransmitter levels in the rat frontoparietal cortex. Jpn J Pharmacol. 1997 Jun;74(2):139-46.
Here we report the first in vivo study of the effects of these two nicotinic agonists on cortical extracellular acetylcholine (ACh), dopamine (DA), norepinephrine (NE) and serotonin (5-HT) levels, measured with a microdialysis probe placed within the frontoparietal cortex in the absence of a cholinesterase inhibitor. |
1(0,0,0,1) |
Details |
| 720202 |
Dalimov DN, Abduvakhabov AA, Aslanov KhA, Sadykov AS, Mikhailov SS: [Reaction of N-[beta-(dialkoxyphosphinyl)-mercaptoethyl] anabasines and their diiodomethylates with human erythrocyte acetylcholinesterase and horse serum butyrylcholinesterase] Dokl Akad Nauk SSSR. 1978;243(1):240-3.
|
1(0,0,0,1) |
Details |